Chronic Phase Chronic Myeloid Leukemia
Oncology·MeSH: Leukemia, Myeloid, Chronic-Phase
Prevalence
12.0 / 100K
Incidence
1.9 / 100K/yr
2 drugs in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| nilotinib | GH Research PLC (GHRS) |
Phase 2(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Chronic Phase Chronic Myeloid Leukemia?
BioSniper tracks 2 drugs in development for Chronic Phase Chronic Myeloid Leukemia across 1 company.
How many clinical trials target Chronic Phase Chronic Myeloid Leukemia?
There are 3 clinical trials targeting Chronic Phase Chronic Myeloid Leukemia tracked by BioSniper.
What is the prevalence of Chronic Phase Chronic Myeloid Leukemia?
The estimated prevalence of Chronic Phase Chronic Myeloid Leukemia is approximately 12.0 per 100,000 population.
Deep-dive into Chronic Phase Chronic Myeloid Leukemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis